Kehua Dongling is a Sino-Japanese joint venture company founded by KHB, Toyobo Co., Ltd. and Mitsubishi Corporation in 1995, specializing in the production of clinical chemistry reagents. To date, the registered capital of the company is USD1.6 million.

The company is a high-tech corporation certified by Shanghai Municipal Government.